findmyKOL
Clinical trialNCT03446781CompletedPhase 3Interventional

Effectiveness and Safety of EN3835 in the Treatment of Cellulite in Women

SponsorEndo USA Inc., a Keenova Therapeutics CompanyEnrollment422Edematous Fibrosclerotic Panniculopathy (Cellulite)
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Endo Clinical Trial Site #1

    Glendale, Arizona, United States

  • Endo Clinical Trial Site #2

    North Little Rock, Arkansas, United States

  • Endo Clinical Trial Site #3

    Beverly Hills, California, United States

  • Endo Clinical Trial Site #4

    Murrieta, California, United States

  • Endo Clinical Trial Site #5

    Newport Beach, California, United States

  • Endo Clinical Trial Site #6

    San Diego, California, United States

  • Endo Clinical Trial Site #7

    Greenwood Village, Colorado, United States

  • Endo Clinical Trial Site #8

    Coral Gables, Florida, United States

  • Endo Clinical Trial Site #9

    Miami, Florida, United States

  • Endo Clinical Trial Site #10

    Nampa, Idaho, United States

  • Endo Clinical Trial Site #11

    Carmel, Indiana, United States

  • Endo Clinical Trial Site #12

    Metairie, Louisiana, United States

  • Endo Clinical Trial Site #13

    New Orleans, Louisiana, United States

  • Endo Clinical Trial Site #14

    Warren, Michigan, United States

  • Endo Clinical Trial Site #15

    Montclair, New Jersey, United States

  • Endo Clinical Trial Site #16

    East Setauket, New York, United States

  • Endo Clinical Trial Site #17

    New York, New York, United States

  • Endo Clinical Trial Site #18

    Cincinnati, Ohio, United States

  • Endo Clinical Trial Site #19

    Nashville, Tennessee, United States

  • Endo Clinical Trial Site #20

    Austin, Texas, United States

  • Endo Clinical Trial Site #21

    Beaumont, Texas, United States

  • Endo Clinical Trial Site #22

    Houston, Texas, United States

  • Endo Clinical Trial Site #23

    San Antonio, Texas, United States

  • Endo Clinical Trial Site #24

    Salt Lake City, Utah, United States

  • Endo Clinical Trial Site #25

    Lynchburg, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
8 Feb 2018
Primary completion
26 Sept 2018
Completion
26 Sept 2018
Last update posted
8 Oct 2020
Registered enrollment
422
Registry id
NCT03446781

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.